Journal profile

Clinical pharmacology and therapeutics

Publisher: Wiley
ISSN0009-9236 | 1532-6535 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.06
Citation rate 4.57 3,124 total citations
h5-index 66 h5 depth signal
Cited share 71.9% 519 of 722
Total citations 3,124 Citation footprint
Metric signal 4.87 External metric anchor
Self-citation 7.3% 227 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 2,060
United Kingdom 514
Netherlands 345
Germany 301
Switzerland 219

Citing Fields of Research

Pharmacology & Toxicology 1,103
Medical Ethics 704
Cancer Drugs 441
Oncology 311
Cardiology 311

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 18,002 Articles tracked across the journal lifetime
Indexed publication set 722 519 cited publications
Last 12 months 429 35.8 publications/month
Open access share 56.6% 243 OA publications in the last year
Leading citing country United States 2,060 citing publications
Leading citing field Pharmacology & Toxicology 1,103 citing publications
Latest tracked publication 20 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v6n5,Sept.-Oct. 1965-
PubMed
v6n5,Sept.-Oct. 1965-
OLDMEDLINE
Active Coverage
Abridged index medicus
Active Coverage
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Pharmacology & Toxicology Medical Ethics Cardiology Genetics & Genomics Cancer Drugs Hematology

Issuing & Sponsoring Bodies

Contributor
American Therapeutic Society

Broad Categories

Drug Therapy Pharmacology Medical Ethics Cardiology Pharmacology & Toxicology Cancer Drugs Genetics & Genomics Hematology

MeSH Descriptors

Drug Therapy Pharmacology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

02
Philip E. Empey, Nita A. Limdi, Dinushika Mohottige et al.
Almost half of individuals with hypertension fail to achieve recommended blood pressure (BP) goals. Pharmacogenetic gene‐drug interactions may alter the efficacy of antihypertensive agents. We conducted a multicenter randomized controlle...
03
Navakanth Raju Ramayanam, Bhawarlal Kavitha, Chitthi Babu Prathisha et al.
Concomitant congestive heart failure (CHF) and diabetes mellitus (DM) patients frequently are treated with polypharmacy, thus potentially increasing the risk of drug–drug interactions (pDDIs). Conventional DDI screening methods often fai...
07
Devam A. Desai, Rodrigo Cristofoletti
Unconjugated antisense oligonucleotides (ASOs) and GalNAc‐conjugated small interfering RNAs (siRNAs) have emerged as transformative therapeutic modalities, but their translation remains hindered by complex pharmacokinetics characterized ...
08
Priya Jayachandran, Jyoti S. Mathad, Nan Zhang et al.
IMPAACT 2001 (NCT02651259) evaluated the safety and pharmacokinetics (PK) of once‐weekly isoniazid and rifapentine in pregnant and postpartum women for tuberculosis prevention. Rifapentine (RPT) and desacetyl rifapentine (desRPT) PK data...

Bibliographical & Catalog Notes

Also issued online.

Official publication of the American Therapeutic Society.

Vol. 1991, no. 1 (JAN 1991)19920901 Notice not published Printed on acid-free paper